Over the past few years, there has been a growing interest in traditional Ayurvedic medicine, which extensively utilizes plants. One such plant is Bacopa monnieri, also known as brahmi, which has gained particular popularity for its cognitive-function-enhancing properties and neuroprotective effects. Numerous studies highlight its antioxidant, anti-inflammatory, anti-stress, anti-anxiety, and even symptom-reducing properties associated with attention deficit–hyperactivity disorder (ADHD). Additionally, in vitro and in vivo studies demonstrate the potential therapeutic applications of this plant and its active compounds, particularly bacosides, in treating Alzheimer’s disease. This review aims to evaluate whether B. monnieri can serve as a potential therapy enhancer and slow the progression of Alzheimer’s disease. We have attempted to clarify the mechanisms of action and the possible clinical application of brahmi in this progressive neurodegenerative brain disorder.

Curcumin, a polyphenolic compound obtained from the rhizome of Curcuma longa, is the main bioactive component of turmeric and exhibits a wide range of biological properties. This naturally occurring polyphenolic compound is widely known for its protective properties on the vascular endothelium and its anti-inflammatory effects. Curcumin has been recognized as a factor in improving antioxidant defenses and lipid metabolism and as a neuroprotective agent. Thanks to its broad spectrum of activity, curcumin is gaining popularity as an ingredient in dietary supplements and as part of a healthy diet that supports overall health. In this article, we will take a closer look at curcumin—based on a review of the current literature, we will learn what curcumin is and what health benefits it can provide.